keyword
Keywords Metabolic disorder complicatio...

Metabolic disorder complications and Diabetes type II

https://read.qxmd.com/read/36683033/clinical-characteristics-of-683-children-and-adolescents-aged-0-18%C3%A2-years-newly-diagnosed-with-type-1-diabetes-mellitus-in-henan-province-a-single-center-study
#21
JOURNAL ARTICLE
Ai Huang, Qiong Chen, Wei Yang, Yan Cui, Qingzhi Wang, Haiyan Wei
BACKGROUND: Type 1 diabetes mellitus (T1DM) is a common chronic systemic disease that threatens the health of children worldwide. Diabetic ketoacidosis (DKA) is the most severe acute complication of diabetes and can lead to death. This study aimed to explore the epidemiological features, clinical manifestations, and risk factors for DKA in children and adolescents newly diagnosed with T1DM in the Department of Endocrinology of the Children's Hospital of Henan Province. METHODS: Medical records of 683 children and adolescents newly diagnosed with T1DM in our center from March 2014 to November 2021 were retrospectively analyzed...
January 23, 2023: BMC Pediatrics
https://read.qxmd.com/read/36476232/understanding-the-risk-of-developing-weight-related-complications-associated-with-different-body-mass-index-categories-a-systematic-review
#22
REVIEW
Adam Ben Taieb, Erika Roberts, Maria Luckevich, Sara Larsen, Carel W le Roux, Paulo Gomes de Freitas, Dingeman Wolfert
BACKGROUND: Obesity and overweight are major risk factors for several chronic diseases. There is limited systematic evaluation of risk equations that predict the likelihood of developing an obesity or overweight associated complication. Predicting future risk is essential for health economic modelling. Availability of future treatments rests upon a model's ability to inform clinical and decision-making bodies.  This systematic literature review aimed to identify studies reporting (1) equations that calculate the risk for individuals with obesity, or overweight with a weight-related complication (OWRC), of developing additional complications, namely T2D, cardiovascular (CV) disease (CVD), acute coronary syndrome, stroke, musculoskeletal disorders, knee replacement/arthroplasty, or obstructive sleep apnea; (2) absolute or proportional risk for individuals with severe obesity, obesity or OWRC developing T2D, a CV event or mortality from knee surgery, stroke, or an acute CV event...
December 7, 2022: Diabetology & Metabolic Syndrome
https://read.qxmd.com/read/36447542/congenital-diaphragmatic-hernia-as-a-presentation-of-mucopolysaccharidosis-in-a-3-year-old-child-a-case-report
#23
Yazan Al-Mashakbeh, Nizar Heissat, Ahmad Al-Shaibei, Nazek Heissat, Abdullah Al-Faqeeh, Ahmad Al-Jeady, Mohammad Al Katatbeh, Laith Khasawneh
Background: Mucopolysaccharidoses (MPS) are rare, metabolic lysosomal storage disorders caused by the deficiency of enzymes required for the stepwise breakdown of glycosaminoglycans (GAGs). We report a case that was discovered to be Mucopolysaccharidosis Type II and was presented to the hospital with signs and symptoms of congenital diaphragmatic hernia. The hernia was repaired, and the patient was discharged on BiPAP and High-flow Oxygen. Case Presentation: A vaginally delivered male child was presented to the hospital with a fever, cough, and shortness of breath...
2022: Medical Journal of the Islamic Republic of Iran
https://read.qxmd.com/read/36418417/cytokine-modulation-by-etanercept-ameliorates-metabolic-syndrome-and-its-related-complications-induced-in-rats-administered-a-high-fat-high-fructose-diet
#24
JOURNAL ARTICLE
Noha F Hassan, Azza H Hassan, Mona R El-Ansary
The aim of the present study was to investigate the effect of etanercept (ETA)-an anti-tumor necrosis factor α (TNF-α) monoclonal antibody-on metabolic disorders such as obesity, hypertension, dyslipidemia, and insulin resistance associated with the metabolic syndrome (MS). MS was induced in rats via high-fat high-fructose (HFHF) administration for 8 weeks. Rats were divided into three groups: negative control, HFHF model, and ETA-treated groups [HFHF + ETA (0.8 mg/kg/twice weekly, subcutaneously) administered in the last 4 weeks]...
November 23, 2022: Scientific Reports
https://read.qxmd.com/read/36362021/histomorphometry-changes-and-decreased-reactivity-to-angiotensin-ii-in-the-ileum-and-colon-of-streptozotocin-induced-diabetic-rats
#25
JOURNAL ARTICLE
Marisa Esteves-Monteiro, Daniela Menezes-Pinto, Mariana Ferreira-Duarte, Patrícia Dias-Pereira, Manuela Morato, Margarida Duarte-Araújo
Diabetes mellitus (DM) is a chronic progressive metabolic disorder associated with several gastrointestinal complications, affecting up to 75% of patients. Knowing that Angiotensin II (AngII) also regulates intestinal contraction, we decided to evaluate changes in ileum and colon histomorphometry and AngII reactivity in a rat model of DM. Streptozotocin (STZ, 55 mg/kg) was administered to induce DM to 24 adult male Wistar rats. Diabetic rats displayed all the characteristic signs of type 1 DM (T1DM) and fecal excretion increased about 4-fold over 14 days, while the excretion of controls remained unaltered...
October 31, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36300424/tryptophan-self-assembly-yields-cytotoxic-nanofibers-containing-amyloid-mimicking-and-cross-seeding-competent-conformers
#26
JOURNAL ARTICLE
Kailash Prasad Prajapati, Bibin Gnanadhason Anand, Masihuzzaman Ansari, Ashu Bhan Tiku, Karunakar Kar
Dietary consumption of Trp via protein-based foods is essential for the maintenance of crucial metabolic processes including the synthesis of proteins and several vital metabolites such as serotonin, melatonin, acetyl CoA, and NADP. However, the abnormal build-up of Trp is known to cause familial hypertryptophanemia and several brain-related medical complications. The molecular mechanism of the onset of such Trp -driven health issues is largely unknown. Here, we show that Trp , under the physiologically mimicked conditions of temperature and buffer, undergoes a concentration driven self-assembly process, yielding amyloid-mimicking nanofibers...
October 27, 2022: Nanoscale
https://read.qxmd.com/read/35893989/development-and-optimization-of-nigella-sativa-nanoemulsion-loaded-with-pioglitazone-for-hypoglycemic-effect
#27
JOURNAL ARTICLE
Tamer M Shehata, Mervt M Almostafa, Heba S Elsewedy
Diabetes mellitus (DM) is a metabolic disorder associated with an increased blood glucose level. The world health burden of DM has increased as a result of numerous causes that necessitates suitable treatment. Pioglitazone (PGZ) is a generally prescribed medication for managing type II diabetes. However, its low solubility creates complications for its formulation. Therefore, the aim of the current study was to incorporate PGZ into a nanoemulsion (NE) formulation prepared with Nigella sativa oil (NSO) to boost the action of PGZ...
July 26, 2022: Polymers
https://read.qxmd.com/read/35477946/network-analysis-reveals-dysregulated-functional-patterns-in-type-ii-diabetic-skin
#28
JOURNAL ARTICLE
Chunan Liu, Sudha Ram, Bonnie L Hurwitz
Skin disorders are one of the most common complications of type II diabetes (T2DM). Long-term effects of high blood glucose leave individuals with T2DM more susceptible to cutaneous diseases, but its underlying molecular mechanisms are unclear. Network-based methods consider the complex interactions between genes which can complement the analysis of single genes in previous research. Here, we use network analysis and topological properties to systematically investigate dysregulated gene co-expression patterns in type II diabetic skin with skin samples from the Genotype-Tissue Expression database...
April 27, 2022: Scientific Reports
https://read.qxmd.com/read/35432555/association-between-poor-sleep-quality-and-glycemic-control-in-adult-patients-with-diabetes-referred-to-endocrinology-clinic-of-guilan-a-cross-sectional-study
#29
JOURNAL ARTICLE
Mojtaba Mehrdad, Mehrnaz Azarian, Amir Sharafkhaneh, Ali Alavi, Roghayeh Zare, Afagh Hassanzadeh Rad, Setila Dalili
Background: Diabetes is a prevalent chronic medical comorbid condition worldwide. Diabetes mellitus is associated with various sleep disorders. Objectives: We aimed to determine the prevalence of poor sleep and the main factors of sleep interruptions in patients with diabetes mellitus. We further evaluated the association of sleep interruptions with glycemic control in this cohort. Methods: We conducted a cross-sectional study on 266 patients with type 1 and type 2 diabetes recruited from a university outpatient endocrinology clinic...
January 2022: International Journal of Endocrinology and Metabolism
https://read.qxmd.com/read/35067153/glucokinase-as-an-emerging-anti-diabetes-target-and-recent-progress-in-the-development-of-its-agonists
#30
REVIEW
Yixin Ren, Li Li, Li Wan, Yan Huang, Shuang Cao
Type 2 diabetes mellitus is a metabolic disorder with complicated pathogenesis, and mono-target therapy often fails to effectively manage the levels of blood glucose. In recent years, the anti-diabetes target glucokinase (GK) has attracted the attention of researchers. It acts as a glucose sensor, triggering counter regulatory responses following a change in glucose levels to aid restoration of normoglycemia. Activation of GK induces glucose metabolism and reduces glucose levels for the treatment of type 2 diabetes...
December 2022: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/35062059/ampk-signaling-in-diabetes-mellitus-insulin-resistance-and-diabetic-complications-a-pre-clinical-and-clinical-investigation
#31
REVIEW
Maliheh Entezari, Danial Hashemi, Afshin Taheriazam, Amirhossein Zabolian, Shima Mohammadi, Farima Fakhri, Mehrdad Hashemi, Kiavash Hushmandi, Milad Ashrafizadeh, Ali Zarrabi, Yavuz Nuri Ertas, Sepideh Mirzaei, Saeed Samarghandian
Diabetes mellitus (DM) is considered as a main challenge in both developing and developed countries, as lifestyle has changed and its management seems to be vital. Type I and type II diabetes are the main kinds and they result in hyperglycemia in patients and related complications. The gene expression alteration can lead to development of DM and related complications. The AMP-activated protein kinase (AMPK) is an energy sensor with aberrant expression in various diseases including cancer, cardiovascular diseases and DM...
February 2022: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/34836865/in-silico-modeling-and-in-vitro-studies-of-2-1-benzothiazine-2-2-dioxide-based-hydrazone-derivatives-as-%C3%AE-glucosidase-inhibitors
#32
JOURNAL ARTICLE
Shakeel Ahmad, Saman Taj, Sana Aslam, Samreen Gul Khan, Tahir Farooq, Usman Ali Ashfaq, Matloob Ahmad
Diabetes mellitus (DM) is a metabolic disorder characterized by frequent urination, hunger and high blood sugar level. α-glucosidase inhibitors are considered as a frontline treatment for the DM. This research article deals with the identification of benzothiazine derivatives as α-glucosidase inhibitors through in-silico techniques and then the confirmation through in-vitro analysis. Molecular docking studies were carried out to find out the binding interactions of targeted molecules with receptor molecule i...
September 2021: Pakistan Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/34823968/a-network-pharmacology-based-strategy-to-explore-the-pharmacological-mechanisms-of-antrodia-camphorata-and-antcin-k-for-treating-type-ii-diabetes-mellitus
#33
JOURNAL ARTICLE
Yi Kuang, Yue Chai, Huifei Su, Jen-Yu Lo, Xue Qiao, Min Ye
BACKGROUND: Diabetes mellitus is a chronic carbohydrate metabolism disorder, which could develop a series of complications and thus lead to poor quality of life or even mortality. Antrodia camphorata is a rare parasitic fungus and has been proven to be effective for treating type II diabetes. PURPOSE: This study aims to evaluate the anti-diabetic activities of A. camphorata and its main compound antcin K, as well as to demonstrate the mechanisms. STUDY DESIGN AND METHODS: Network pharmacology was used to explore the potential targets of 12 major compounds of A...
November 15, 2021: Phytomedicine
https://read.qxmd.com/read/34703115/estimation-and-comparison-of-salivary-flow-rate-and-its-composition-in-diabetic-patients-and-nondiabetic-patients-a-pilot-study
#34
JOURNAL ARTICLE
S Dhanarathna, Nadeem Jeddy, B Sabarinath, G B Protyusha
BACKGROUND: Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia irregularities in the metabolism of carbohydrates, lipids and protein. It is often associated with the development of microvascular and macrovascular complications and neuropathies. The health of oral tissues is known to be related to the quality and quantity of saliva both of which may be altered in diabetes. AIM: The aim of the present study was to determine the salivary flow rate, electrolytes and total proteins in saliva of Type II diabetic patients...
May 2021: Journal of Oral and Maxillofacial Pathology: JOMFP
https://read.qxmd.com/read/34305402/effect-of-leptin-on-chronic-inflammatory-disorders-insights-to-therapeutic-target-to-prevent-further-cardiovascular-complication
#35
REVIEW
Gashaw Dessie, Birhanu Ayelign, Yonas Akalu, Tewodros Shibabaw, Meseret Derbew Molla
In response to obesity-associated chronic inflammatory disorders, adipose tissue releases a biologically active peptide known as leptin. Leptin activates the secretion of chemical mediators, which contribute to the pathogenesis of chronic inflammatory disorders, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and psoriasis. Conversely, adiposity and obesity are the major aggravating risk factors in the pathogenesis of metabolic syndrome (MetS), including type II diabetes mellitus and obesity-associated hypertension...
2021: Diabetes, Metabolic Syndrome and Obesity
https://read.qxmd.com/read/34222082/self-care-and-related-factors-in-patients-with-type-ii-diabetes-in-iran
#36
JOURNAL ARTICLE
Nazi Nejat, Ali Khan Mohamadi Hezave, Seyed Mohammad Aghae Pour, Korosh Rezaei, Azam Moslemi, Fatemeh Mehrabi
PURPOSE: To assess Self-care and related factors in patients with type II diabetes in Iran. METHODS: This descriptive cross-sectional study was performed on 100 patients with type II diabetes who were referred to specialized diabetes centers related to Arak University of Medical Sciences in Iran. Data collection was done using a researcher-made questionnaire. The questionnaire consisted of three parts (the first part was demographic information, the second part was self-care behaviors such as diet, exercise, control, treatment, and prevention of complications over the past seven days, and the third part was factors influencing patients' self-care behaviors)...
June 2021: Journal of Diabetes and Metabolic Disorders
https://read.qxmd.com/read/34178826/distress-and-depression-among-patients-with-diabetes-mellitus-prevalence-and-associated-factors-a-cross-sectional-study
#37
JOURNAL ARTICLE
Mahtab Niroomand, Sepideh Babaniamansour, Ehsan Aliniagerdroudbari, Ali Golshaian, Azadeh Mazaheri Meibodi, Abdorrahim Absalan
PURPOSE: This study aimed to validate the internal consistency of the Persian version of the diabetes distress scale-17 (DDS-17) and to investigate the prevalence of diabetes distress (DD), depression, and possible relevant factors. METHODS: This was a cross-sectional study on 820 diabetes patients (62.4 % females) in Tehran, Iran between January and June 2017. The Ethics Committee of Shahid Beheshti University of Medical Sciences approved the protocol. Patients filled out a demographic and health survey, DDS-17, the Beck Depression Inventory Second Edition (BDI-II) and the Summary of Diabetes Self-Care Activities Measure (SDSCA)...
June 2021: Journal of Diabetes and Metabolic Disorders
https://read.qxmd.com/read/34079310/predictors-of-poor-plasma-glucose-maintenance-in-type-ii-diabetic-people-with-ophthalmic-complication-the-case-of-dessie-hospitals-in-ethiopia
#38
JOURNAL ARTICLE
Mohammed Abdu Seid, Baye Dagnew
Background: Diabetes mellitus, the commonest metabolic disorder, leads to cardiovascular diseases, neurological problems, kidney injury, and visual disturbances. Such complications can be prevented by maintaining plasma glucose level in the normal range, including ophthalmic complications. Hence, this study intended to pinpoint predictors of poor plasma glucose maintenance in type II DM people with ophthalmic complication. Methods: We conducted a cross-sectional survey using simple random sampling approach to recruit participants...
2021: Diabetes, Metabolic Syndrome and Obesity
https://read.qxmd.com/read/34071722/a-review-on-obesity-management-through-natural-compounds-and-a-green-nanomedicine-based-approach
#39
REVIEW
Monika Bhardwaj, Poonam Yadav, Divya Vashishth, Kavita Sharma, Ajay Kumar, Jyoti Chahal, Sunita Dalal, Sudhir Kumar Kataria
Obesity is a serious health complication in almost every corner of the world. Excessive weight gain results in the onset of several other health issues such as type II diabetes, cancer, respiratory diseases, musculoskeletal disorders (especially osteoarthritis), and cardiovascular diseases. As allopathic medications and derived pharmaceuticals are partially successful in overcoming this health complication, there is an incessant need to develop new alternative anti-obesity strategies with long term efficacy and less side effects...
May 28, 2021: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/33860201/identification-of-small-molecule-inhibitors-of-human-inositol-hexakisphosphate-kinases-by-high-throughput-screening
#40
JOURNAL ARTICLE
Gangling Liao, Wenjuan Ye, Tyler Heitmann, Glen Ernst, Michael DePasquale, Laiyi Xu, Michael Wormald, Xin Hu, Marc Ferrer, Robert K Harmel, Dorothea Fiedler, James Barrow, Huijun Wei
Inositol hexakisphosphate kinases (IP6Ks) catalyze pyrophosphorylation of inositol hexakisphosphate (IP6) into inositol 5-diphospho-1,2,3,4,6-pentakisphosphate (IP7), which is involved in numerous areas of cell physiology including glucose homeostasis, blood coagulation, and neurological development. Inhibition of IP6Ks may be effective for the treatment of Type II diabetes, obesity, metabolic complications, thrombosis, and psychiatric disorders. We performed a high-throughput screen (HTS) of 158 410 compounds for IP6K1 inhibitors using a previously developed ADP-Glo Max assay...
April 9, 2021: ACS Pharmacology & Translational Science
keyword
keyword
48933
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.